Clinical Trials Logo

Clinical Trial Summary

Cytobacteriological examination of sputum and bacteriological sampling in the middle meatus.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03494894
Study type Observational
Source Centre Hospitalier Intercommunal Creteil
Contact Ralph Epaud, MD
Phone 0415175419
Email ralph.epaud@chicreteil.fr
Status Recruiting
Phase
Start date June 1, 2017
Completion date December 2018

See also
  Status Clinical Trial Phase
Terminated NCT02769637 - Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
Recruiting NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Recruiting NCT03566550 - Gut Imaging for Function & Transit in Cystic Fibrosis
Completed NCT02449785 - Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences N/A
Terminated NCT02170025 - Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients Phase 2
Completed NCT02465450 - Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis Phase 2
Recruiting NCT03335202 - Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis N/A
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Completed NCT00903201 - 28 Day Repeat Dose in Cystic Fibrosis Patients Phase 2
Recruiting NCT03181932 - A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients Phase 3
Not yet recruiting NCT03645473 - Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System N/A
Enrolling by invitation NCT03628456 - Effect of HFCWO Vests on Spirometry Measurements N/A
Not yet recruiting NCT02748798 - Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders Early Phase 1
Not yet recruiting NCT03617718 - Project 2 Airway Potential Hydrogen (pH) in Asthma Phase 1/Phase 2
Recruiting NCT02721498 - Improving Outcome Measures For Adult CF ACT Trials N/A
Completed NCT02823964 - EASY: Extended Access to Sollpura Over Years Phase 4
Completed NCT02875366 - A Study of the Effects of Lumacaftor/Ivacaftor on Exercise Tolerance in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation Phase 4
Completed NCT02730208 - A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation Phase 2
Completed NCT02421120 - Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients Phase 4
Completed NCT02564354 - Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation Phase 1